FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of SMS Pharmaceuticals IPO.
March 2, 2024 1:51:00 PM
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.
Published by : India InfolineApril 12, 2024 3:30:00 AM
SMS Pharmaceuticals Ltd share price was down by -1.45% from the previous closing price of ?207.40. Who are peers of SMS Pharmaceuticals Ltd? The peers of SMS Pharmaceuticals Ltd are Sun ...
Published by : Business TodayApril 4, 2024 3:30:00 AM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Published by : MorningstarMarch 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechMarch 18, 2024 5:26:00 PM
The potential offering would add to the growing number of healthcare firms looking to list amid a stuttering rebound in the IPO market in the United States. Healthcare provider PACS Group last ...
Published by : ReutersFebruary 3, 2024 8:13:00 PM
In 2023, the losses delivered by nearly all European IPOs made for a tiny shortlist for this award, but German specialist glassmaker Schott Pharma would shine in any year. In a year of crashing ...
Published by : International Financing ReviewMarch 21, 2024 10:23:00 PM
Reddit shares soared in their stock-market debut Thursday, an endorsement for the social-media company whose users fueled the meme-stocks craze and a boost for other companies eyeing 2024 IPOs.
Published by : Wall Street JournalApril 19, 2024 3:30:00 AM
Questcor Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders.
Published by : ForbesApril 23, 2024 5:53:00 PM
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator product candidates to treat solid cancers ...
Published by : Seeking AlphaApril 20, 2024 11:39:00 PM
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines in Canada and the United States. The company�s lead product ...
Published by : Seeking AlphaApril 16, 2024 3:30:00 AM
Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation ...
Published by : Benzinga.comApril 16, 2024 3:30:00 AM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Published by : MorningstarIPO Allotment Status is now available for SMS Pharmaceuticals Limited IPO. Issue was closed on February 08, 2007.
SMS Pharmaceuticals Ltd. listing date & Info :
Listing On: Wednesday, February 28, 2007
BSE Script Code: 532815
NSE Symbol: SMSPHARMA
Listing in:
ISIN: INE812G01017
Issue Price: Rs. 380/- Per share (Face Value of Rs. 10/-)
IPO Allotment Status is now available for SMS Pharmaceuticals Limited IPO. Issue was closed on February 08, 2007.
SMS Pharmaceuticals Limited is leading manufacturers and exporters of Active Pharmacy Ingredients and pharmaceutical intermediates in India, commonly known as Bulk Drug Manufacturer. SMS Pharmaceuticals Limited is coming up with initial public offer of 2,977,000 Equity Shares of Rs. 10/- Each.
The float is being routed through a 100 per cent book-building with price band between Rs 360 and Rs 380 a share. The company intends to list its shares on both the BSE and NSE.
Issue Open: 05 February 2007
Issue Close: 08 February 2007
The SMS Pharmaceuticals IPO is proposed to open on February 5, 2007. The IPO application ends on February 8, 2007.
Retail investors can apply in the retail or non-institutional investor category from February 5, 2007 to February 8, 2007. The SMS Pharmaceuticals IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The SMS Pharmaceuticals IPO will open for subscription on February 5, 2007. The public issue will close on February 8, 2007.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|